目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. DEFINITION
2.2. SCOPE OF THE STUDY
2.3. RESEARCH OBJECTIVE
2.4. ASSUMPTIONS
2.5. LIMITATIONS

3. RESEARCH METHODOLOGY
3.1. OVERVIEW
3.2. DATA MINING
3.3. SECONDARY RESEARCH
3.4. PRIMARY RESEARCH
3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
3.5. FORECASTING TECHNIQUE
3.6. MARKET SIZE ESTIMATION
3.6.1. BOTTOM-UP APPROACH
3.6.2. TOP-DOWN APPROACH
3.7. DATA TRIANGULATION
3.8. VALIDATION

4. MARKET DYNAMICS
4.1. OVERVIEW
4.2. DRIVERS
4.2.1. GROWING DEMAND FOR MINIMALLY INVASIVE SPINE SURGERY
4.2.2. RISING AGEING DEMOGRAPHY
4.2.3. INCREASING PREVALENCE OF SPINAL DISORDERS
4.3. RESTRAINTS
4.3.1. SIDE EFFECTS ASSOCIATED WITH THE SPINAL IMPLANT
4.3.2. HIGH COST OF SPINE TREATMENT
4.4. OPPORTUNITIES
4.4.1. GROWING DEMAND FOR SPINAL IMPLANTS

5. MARKET FACTOR ANALYSIS
5.1. VALUE CHAIN ANALYSIS
5.1.1. R&D
5.1.2. MANUFACTURING
5.1.3. DISTRIBUTION AND SALES
5.1.4. POST-SALES MONITORING
5.2. PORTER’S FIVE FORCES ANALYSIS
5.2.1. BARGAINING POWER OF SUPPLIERS
5.2.2. BARGAINING POWER OF BUYERS
5.2.3. THREAT OF NEW ENTRANTS
5.2.4. THREAT OF SUBSTITUTES
5.2.5. INTENSITY OF RIVALRY
5.3. COVID-19 IMPACT ANALYSIS
5.3.1. IMPACT ON SUPPLY CHAIN
5.3.2. IMPACT ON PRODUCT TYPEION
5.3.3. IMPACT ON REGIONS
5.3.4. DEMAND-SUPPLY GAP ANALYSIS
5.3.5. IMPACT ON PRICING

6. GLOBAL SPINAL IMPLANT MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. SPINAL FUSION DEVICES
6.2.1. THORACIC FUSION & LUMBAR FUSION DEVICES
6.2.2. CERVICAL FUSION DEVICES
6.2.3. EXPANDABLE FUSION CAGES
6.2.4. OTHERS
6.3. NON-FUSION DEVICES
6.3.1. DYNAMIC STABILIZATION DEVICES
6.3.2. ARTIFICIAL DISCS
6.3.3. ANNULUS REPAIR DEVICES
6.3.4. NUCLEAR DISC PROSTHESES
6.3.5. OTHERS
6.4. SPINE BIOLOGICS
6.5. OTHERS

7. GLOBAL SPINAL IMPLANT MARKET, BY MATERIAL
7.1. OVERVIEW
7.2. METALLIC MATERIAL
7.3. POLYMERS MATERIAL
7.4. CERAMIC MATERIAL
7.5. OTHERS

8. GLOBAL SPINAL IMPLANT MARKET, BY PROCEDURE
8.1. OVERVIEW
8.2. OPEN SURGERY
8.3. MINIMALLY INVASIVE SURGERY

9. GLOBAL SPINAL IMPLANT MARKET, BY END USER
9.1. OVERVIEW
9.2. HOSPITALS
9.3. ORTHOPEDIC CENTERS
9.4. OTHERS

10. GLOBAL SPINAL IMPLANT MARKET, BY REGION
10.1. OVERVIEW
10.1. NORTH AMERICA
10.1.1. US
10.1.2. CANADA
10.2. EUROPE
10.2.1. GERMANY
10.2.2. FRANCE
10.2.3. UK
10.2.4. ITALY
10.2.5. SPAIN
10.2.6. REST OF EUROPE
10.3. ASIA-PACIFIC
10.3.1. JAPAN
10.3.2. CHINA
10.3.3. INDIA
10.3.4. AUSTRALIA
10.3.5. SOUTH KOREA
10.3.6. REST OF ASIA-PACIFIC
10.4. REST OF THE WORLD
10.4.1. MIDDLE EAST
10.4.2. AFRICA
10.4.3. LATIN AMERICA

11. COMPANY LANDSCAPE
11.1. OVERVIEW
11.2. COMPETITIVE ANALYSIS
11.3. MARKET SHARE ANALYSIS
11.4. MAJOR GROWTH STRATEGY IN THE GLOBAL SPINAL IMPLANT MARKET
11.5. COMPETITIVE BENCHMARKING
11.6. LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL SPINAL IMPLANT MARKET
11.7. KEY DEVELOPMENTS AND GROWTH STRATEGIES
11.7.1. PRODUCT APPROVALS AND PRODUCT LAUNCHES
11.7.2. PARTNERSHIP/COLLABORATION
11.7.3. EXPANSIONS/AGREEMENT
11.7.4. MERGERS & ACQUISITIONS
11.8. MAJOR PLAYERS FINANCIAL MATRIX
11.8.1. SALES & OPERATING INCOME, 2022
11.8.2. MAJOR PLAYERS R&D EXPENDITURE. 2022

12. COMPANY PROFILES
12.1. MEDTRONIC PLC
12.1.1. COMPANY OVERVIEW
12.1.2. FINANCIAL OVERVIEW
12.1.3. PRODUCTS OFFERED
12.1.4. KEY DEVELOPMENTS
12.1.5. SWOT ANALYSIS
12.1.6. KEY STRATEGIES
12.2. JOHNSON & JOHNSON SERVICES, INC.
12.2.1. COMPANY OVERVIEW
12.2.2. FINANCIAL OVERVIEW
12.2.3. PRODUCTS OFFERED
12.2.4. KEY DEVELOPMENTS
12.2.5. SWOT ANALYSIS
12.2.6. KEY STRATEGIES
12.3. STRYKER CORPORATION
12.3.1. COMPANY OVERVIEW
12.3.2. FINANCIAL OVERVIEW
12.3.3. PRODUCTS OFFERED
12.3.4. KEY DEVELOPMENTS
12.3.5. SWOT ANALYSIS
12.3.6. KEY STRATEGIES
12.4. B. BRAUN MELSUNGEN AG
12.4.1. COMPANY OVERVIEW
12.4.2. FINANCIAL OVERVIEW
12.4.3. PRODUCTS OFFERED
12.4.4. KEY DEVELOPMENTS
12.4.5. SWOT ANALYSIS
12.4.6. KEY STRATEGIES
12.5. NUVASIVE, INC.
12.5.1. COMPANY OVERVIEW
12.5.2. FINANCIAL OVERVIEW
12.5.3. PRODUCTS OFFERED
12.5.4. KEY DEVELOPMENTS
12.5.5. SWOT ANALYSIS
12.5.6. KEY STRATEGIES
12.6. ZIMMER BIOMET HOLDINGS INC.
12.6.1. COMPANY OVERVIEW
12.6.2. FINANCIAL OVERVIEW
12.6.3. PRODUCTS OFFERED
12.6.4. KEY DEVELOPMENTS
12.6.5. SWOT ANALYSIS
12.6.6. KEY STRATEGIES
12.7. ORTHOFIX MEDICAL INC.
12.7.1. COMPANY OVERVIEW
12.7.2. FINANCIAL OVERVIEW
12.7.3. PRODUCTS OFFERED
12.7.4. KEY DEVELOPMENTS
12.7.5. SWOT ANALYSIS
12.7.6. KEY STRATEGIES
12.8. GLOBUS MEDICAL
12.8.1. COMPANY OVERVIEW
12.8.2. FINANCIAL OVERVIEW
12.8.3. PRODUCTS OFFERED
12.8.4. KEY DEVELOPMENTS
12.8.5. SWOT ANALYSIS
12.9. ALPHATEC
12.9.1. COMPANY OVERVIEW
12.9.2. FINANCIAL OVERVIEW
12.9.3. PRODUCTS OFFERED
12.9.4. KEY DEVELOPMENTS
12.9.5. SWOT ANALYSIS
12.9.6. KEY STRATEGIES
12.10. ULRICH MEDICAL
12.10.1. COMPANY OVERVIEW
12.10.2. FINANCIAL OVERVIEW
12.10.3. PRODUCTS OFFERED
12.10.4. KEY DEVELOPMENTS
12.10.5. SWOT ANALYSIS
12.10.6. KEY STRATEGIES

13. APPENDIX
13.1. REFERENCES
13.2. RELATED REPORTS